Leo sold just $400K worth of shares to Aspire in t
Post# of 72440
"As of September 30, 2017, the available balance is approximately $29.6 million."
"As of September 30, 2017, we had approximately $2.9 million in cash compared to $4.1 million of cash as of June 30, 2017. We anticipate that future budget expenditures will be approximately $15 million for the next twelve months, including approximately $10 million for clinical activities, supportive research, and drug product development."
Current OS = 140,126,830 shares
Previous OS = 137,874,421 shares
OS increase in the last quarter = 1.63%
https://www.sec.gov/Archives/edgar/data/13552...ix_10q.htm